查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813982

被忽视的热带疾病治疗市场规模、份额和趋势分析报告：按疾病、产品、地区和细分市场预测，2025-2033 年

Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report By Disease (Dengue, Rabies, Trachoma, Chagas Disease), By Product (Drugs, Vaccines), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

被忽视的热带疾病治疗市场摘要

预计 2024 年全球被忽视的热带疾病治疗市场价值为 39.6 亿美元，到 2033 年将达到 60.4 亿美元，2025 年至 2033 年的复合年增长率为 4.78%。

这些治疗的需求是由低收入地区被忽视的热带疾病的日益流行，以及药物开发的进步和旨在根除这些疾病的全球卫生倡议所推动的。

被忽视的热带疾病治疗市场受到各种全球卫生倡议、药物研发进展和创新给药方式的显着影响。推动该市场成长的关键因素是各国政府和国际卫生组织日益增长的关注。世界卫生组织 (WHO) 有效协调了针对淋巴丝虫病、沙眼和土源性蠕虫等疾病的大规模药物管理 (MDA) 计画。据 WHO 称，2025 年 4 月，美国撤回了对被忽视热带疾病 (NTD) 计画的资助，19 年间影响了 47 项宣传活动。这次撤资影响了 1.43 亿人，并扰乱了大规模治疗活动。经费削减也阻碍了研究，并威胁到根除淋巴丝虫病、盘尾丝虫病和血吸虫病等疾病的进展。这些努力，加上全球对抗爱滋病、结核病和疟疾基金等组织的承诺，对于减轻疾病负担至关重要，尤其是在撒哈拉以南非洲和东南亚等资源匮乏的地区。

被忽视的热带疾病治疗市场的另一个关键驱动力是专注于改进药物配方，以应对被忽视的疾病带来的独特挑战。正在开发新的治疗方法以提高疗效、缩短治疗时间并提高患者的依从性。根据通讯报道，诺华公司于 2025 年 5 月承诺，儘管资金可能削减，但仍将继续生产疟疾和麻风病治疗药物。该公司每年生产 2,800 万个疗程的疟疾治疗药物，其中大部分以非营利价格出售。儘管面临国际援助减少的挑战，诺华仍投资约 4.9 亿美元用于疟疾和被忽视的热带疾病研究，并致力于提供基本药物。儘管全球卫生资金面临潜在挑战，例如官方发展援助削减，但这些公司继续在确保最需要的人获得治疗方面发挥关键作用。

在技​​术进步方面，新型药物输送系统与数位健康创新的结合正在提高治疗的有效性和可及性。例如，奈米技术正在被研究作为提高药物生物生物有效性的一种方法，从而能够在资源有限的环境中实现更有效的治疗。 2025年7月，瑞士卫​​生当局批准了Coatem Baby（也称为Riamet Baby），这是第一种专为新生儿和体重少于11磅的婴儿设计的疟疾治疗药物。这种治疗方法由疟疾药物研发基金与诺华公司合作开发，旨在填补一个关键的治疗空白。它将在几个非洲国家推广，在这些国家，疟疾仍然是五岁以下儿童死亡的主要原因。这些技术核准不仅改善了治疗效果，还使以前缺乏可靠医疗选择的人更容易获得治疗。此外，行动医疗技术正在帮助缩小医疗服务可近性的差距，使偏远地区能够更好地监测和管理疾病，进一步增加市场潜力。

这些进展反映出，在政府、製药公司和国际卫生组织合作的推动下，NTD治疗领域正蓬勃发展。随着新药配方的出现、大型製药企业的承诺以及技术创新，市场有望继续发展，最终实现控制并根除被忽视的热带疾病的目标。

目录

第一章调查方法与范围

第二章执行摘要

3. 被忽视的热带疾病治疗市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析-波特五力分析
    • PESTLE分析
    • 管道分析
    • 专利到期分析
    • 定价分析

第四章被忽视的热带疾病治疗市场：疾病业务分析

  • 2024 年及 2033 年疾病市占率
  • 疾病细分仪表板
  • 2021-2033 年市场规模与预测、疾病特定趋势分析
  • 登革热
  • 狂犬病
  • 沙眼
  • 布鲁里溃疡
  • 约斯
  • 麻风
  • 南美锥虫病
  • 非洲人类锥虫病（昏睡病）
  • 利什曼原虫症
  • 土源性蠕虫病
  • 其他的

第五章被忽视的热带疾病治疗市场：产品业务分析

  • 2024年及2033年产品市场份额
  • 产品细分仪表板
  • 市场规模、预测与趋势分析（按产品，2021-2033 年）
  • 製药
  • 疫苗

第六章被忽视的热带疾病治疗市场：区域估计和趋势分析

  • 2024 年及 2033 年区域市占率分析
  • 区域市场仪表板
  • 2021-2033 年市场规模与预测趋势分析：
  • 北美洲
    • 按国家/地区，2021-2033 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 参与者概览
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • F. Hoffmann-La Roche Ltd
    • Bayer AG
    • GlaxoSmithKline plc
    • Novartis AG
    • Pfizer, Inc.
    • Eisai Co. Ltd.
    • Sanofi
    • Astellas Pharma
    • Takeda Pharmaceutical Company Limited
    • Gilead Sciences.
Product Code: GVR-3-68038-787-2

Neglected Tropical Disease Treatment Market Summary

The global neglected tropical disease treatment market size was estimated at USD 3.96 billion in 2024 and is projected to reach USD 6.04 billion by 2033, growing at a CAGR of 4.78% from 2025 to 2033. The demand for these treatments is driven by the increasing prevalence of neglected tropical diseases in low-income regions, as well as advancements in drug development and global health initiatives aimed at eradicating these diseases.

Various global health initiatives, advancements in drug development, and innovative delivery methods greatly influence the neglected tropical disease treatment market. A major factor driving growth in this market is increasing attention from governments and international health organizations. The World Health Organization (WHO) has effectively coordinated mass drug administration (MDA) programs for diseases like lymphatic filariasis, trachoma, and soil-transmitted helminths. According to the World Health Organization (WHO), in April 2025, the United States withdrew funding from NTD programs, impacting 47 campaigns over 19 years. This withdrawal affected 143 million people and disrupted mass treatment efforts. The funding reductions also impeded research, threatening progress toward eliminating diseases such as lymphatic filariasis, onchocerciasis, and schistosomiasis. These efforts, along with commitments from organizations like the Global Fund to Fight AIDS, Tuberculosis, and Malaria, are essential in reducing the disease burden in resource-limited settings, especially in sub-Saharan Africa and Southeast Asia.

Another significant driver of the NTD treatment market is the focus on advancing drug formulations to address the unique challenges posed by neglected diseases. New treatments are being developed to improve efficacy, reduce treatment duration, and enhance patient compliance. According to Reuters, in May 2025, Novartis committed to continuing the production of malaria and leprosy medicines despite potential funding cuts. The company produces 28 million malaria treatment courses annually, mostly sold at not-for-profit prices. Despite challenges from reduced international aid, Novartis remains dedicated to supplying essential medicines, investing nearly USD 490 million in research for malaria and neglected tropical diseases. Despite potential challenges in global health funding, such as cuts in official development assistance, these companies continue to play a vital role in ensuring that treatments remain available to those who need them the most.

In terms of technological advancements, the integration of novel drug delivery systems and digital health innovations is improving both the effectiveness and accessibility of treatments. Nanotechnology, for example, is being explored as a way to enhance the bioavailability of drugs, allowing for more effective treatments even in resource-constrained environments. In July 2025, Swiss medical authorities approved Coartem Baby (also known as Riamet Baby), the first malaria treatment specifically designed for newborns and infants weighing under 11 pounds. Developed by Medicines for Malaria Venture in collaboration with Novartis, the drug addresses a critical treatment gap. It is expected to be rolled out in several African nations, where malaria remains a leading cause of death among children under five. These innovations are not only improving therapeutic outcomes but also making treatments more accessible to populations that previously lacked reliable healthcare options. Additionally, mobile health technologies are helping to bridge the gap in healthcare access, enabling better disease monitoring and management in remote areas, further enhancing the market's potential.

These developments reflect a growing momentum in the NTD treatment space, driven by collaborative efforts between governments, pharmaceutical companies, and global health organizations. With new drug formulations, the commitment of major pharmaceutical players, and technological innovations, the market is poised to continue evolving in its mission to control and ultimately eradicate neglected tropical diseases.

Global Neglected Tropical Disease Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neglected tropical disease treatment market report based on disease, product, and region:

  • Disease Outlook (Revenue, USD Million, 2021 - 2033)
  • Dengue
  • Rabies
  • Trachoma
  • Buruli Ulcer
  • Yaws
  • Leprosy
  • Chagas Disease
  • Human African Trypanosomiasis (Sleeping Sickness)
  • Leishmaniases
  • Soil-transmitted Helminthiases
  • Others
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Drugs
    • Anti-Parasite
    • Antifungal
    • Antibiotics
    • Others
  • Vaccines
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease
    • 1.2.2. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Neglected Tropical Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Neglected Tropical Disease Treatment Market: Disease Business Analysis

  • 4.1. Disease Market Share, 2024 & 2033
  • 4.2. Disease Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Disease, 2021 to 2033 (USD Million)
  • 4.4. Dengue
    • 4.4.1. Dengue Market, 2021 - 2033 (USD Million)
  • 4.5. Rabies
    • 4.5.1. Rabies Market, 2021 - 2033 (USD Million)
  • 4.6. Trachoma
    • 4.6.1. Trachoma Market, 2021 - 2033 (USD Million)
  • 4.7. Buruli Ulcer
    • 4.7.1. Buruli Ulcer Market, 2021 - 2033 (USD Million)
  • 4.8. Yaws
    • 4.8.1. Yaws Market, 2021 - 2033 (USD Million)
  • 4.9. Leprosy
    • 4.9.1. Leprosy Market, 2021 - 2033 (USD Million)
  • 4.10. Chagas Disease
    • 4.10.1. Chagas Disease Market, 2021 - 2033 (USD Million)
  • 4.11. Human African Trypanosomiasis (Sleeping Sickness)
    • 4.11.1. Human African Trypanosomiasis (Sleeping Sickness) Market, 2021 - 2033 (USD Million)
  • 4.12. Leishmaniases
    • 4.12.1. Leishmaniases Market, 2021 - 2033 (USD Million)
  • 4.13. Soil-transmitted Helminthiases
    • 4.13.1. Soil-transmitted Helminthiases Market, 2021 - 2033 (USD Million)
  • 4.14. Others
    • 4.14.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Neglected Tropical Disease Treatment Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2033
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Drugs
    • 5.4.1. Drugs Market, 2021 - 2033 (USD Million)
    • 5.4.2. Anti-Parasite
      • 5.4.2.1. Anti-Parasite Market, 2021 - 2033 (USD Million)
    • 5.4.3. Antifungal
      • 5.4.3.1. Antifungal Market, 2021 - 2033 (USD Million)
    • 5.4.4. Antibiotics
      • 5.4.4.1. Antibiotics Market, 2021 - 2033 (USD Million)
    • 5.4.5. Others
      • 5.4.5.1. Others Market, 2021 - 2033 (USD Million)
  • 5.5. Vaccines
    • 5.5.1. Vaccines Market, 2021 - 2033 (USD Million)

Chapter 6. Neglected Tropical Disease Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Neglected Tropical Disease Treatment Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Uk Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. F. Hoffmann-La Roche Ltd
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Disease Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Bayer AG
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Disease Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. GlaxoSmithKline plc
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Disease Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Novartis AG
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Disease Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Pfizer, Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Disease Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Eisai Co. Ltd.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Disease Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Sanofi
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Disease Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Astellas Pharma
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Disease Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Takeda Pharmaceutical Company Limited
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Disease Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Gilead Sciences.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Disease Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global neglected tropical disease treatment market, by region, 2021 - 2033 (USD Million)
  • Table 4. Global neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 5. Global neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 6. North America neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 7. North America neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 8. North America neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 9. U.S. neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 10. U.S. neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 11. Canada neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 12. Canada neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 13. Mexico neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 14. Mexico neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 15. Europe neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 16. Europe neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 17. Europe neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 18. UK neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 19. UK neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 20. Germany neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 21. Germany neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 22. France neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 23. France neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 24. Italy neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 25. Italy neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 26. Spain neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 27. Spain neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 28. Norway neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 29. Norway neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 30. Denmark neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 31. Denmark neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 32. Sweden neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 33. Sweden neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 34. Asia Pacific neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 35. Asia Pacific neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 36. Asia Pacific neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 37. Japan neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 38. Japan neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 39. China neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 40. China neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 41. India neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 42. India neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 43. Australia neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 44. Australia neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 45. South Korea neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 46. South Korea neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 47. Thailand neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 48. Thailand neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 49. Latin America neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 50. Latin America neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 51. Latin America neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 52. Brazil neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 53. Brazil neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 54. Argentina neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 55. Argentina neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 56. Middle East & Africa Neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 57. Middle East & Africa neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 58. Middle East & Africa neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 59. South Africa neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 60. South Africa neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 61. Saudi Arabia neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 62. Saudi Arabia neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 63. UAE neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 64. UAE neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 65. Kuwait neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 66. Kuwait neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Neglected tropical disease treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and disease outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Neglected tropical disease treatment market dynamics
  • Fig. 12 Neglected tropical disease treatment market: Porter's five forces analysis
  • Fig. 13 Neglected tropical disease treatment market: PESTLE analysis
  • Fig. 14 Dengue market, 2021 - 2033 (USD Million)
  • Fig. 15 Rabies market, 2021 - 2033 (USD Million)
  • Fig. 16 Trachoma market, 2021 - 2033 (USD Million)
  • Fig. 17 Buruli ulcer market, 2021 - 2033 (USD Million)
  • Fig. 18 Yaws market, 2021 - 2033 (USD Million)
  • Fig. 19 Leprosy market, 2021 - 2033 (USD Million)
  • Fig. 20 Human african trypanosomiasis (sleeping sickness) market, 2021 - 2033 (USD Million)
  • Fig. 21 Leishmaniases market, 2021 - 2033 (USD Million)
  • Fig. 22 Soil-transmitted helminthiases market, 2021 - 2033 (USD Million)
  • Fig. 23 Others market, 2021 - 2033 (USD Million)
  • Fig. 24 Product market, 2021 - 2033 (USD Million)
  • Fig. 25 Drugs market, 2021 - 2033 (USD Million)
  • Fig. 26 Anti-Parasite market, 2021 - 2033 (USD Million)
  • Fig. 27 Antifungal market, 2021 - 2033 (USD Million)
  • Fig. 28 Antibiotics market, 2021 - 2033 (USD Million)
  • Fig. 29 Others market, 2021 - 2033 (USD Million)
  • Fig. 30 Vaccines market, 2021 - 2033 (USD Million)
  • Fig. 31 Neglected tropical disease treatment market revenue, by region
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. country dynamics
  • Fig. 35 U.S. neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 36 Canada country dynamics
  • Fig. 37 Canada neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico country dynamics
  • Fig. 39 Mexico neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 40 Europe neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 41 UK country dynamics
  • Fig. 42 UK neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 43 Germany country dynamics
  • Fig. 44 Germany neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 45 France country dynamics
  • Fig. 46 France neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 47 Italy country dynamics
  • Fig. 48 Italy neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain country dynamics
  • Fig. 50 Spain neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 51 Norway country dynamics
  • Fig. 52 Norway neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 53 Sweden country dynamics
  • Fig. 54 Sweden neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 55 Denmark country dynamics
  • Fig. 56 Denmark neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 58 Japan country dynamics
  • Fig. 59 Japan neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 60 China country dynamics
  • Fig. 61 China neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 62 India country dynamics
  • Fig. 63 India neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 64 Australia country dynamics
  • Fig. 65 Australia neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea country dynamics
  • Fig. 67 South Korea neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 68 Thailand country dynamics
  • Fig. 69 Thailand neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 70 Latin America neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 71 Brazil country dynamics
  • Fig. 72 Brazil neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 73 Argentina country dynamics
  • Fig. 74 Argentina neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 75 MEA neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 76 South Africa country dynamics
  • Fig. 77 South Africa neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 78 Saudi Arabia country dynamics
  • Fig. 79 Saudi Arabia neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 80 UAE country dynamics
  • Fig. 81 UAE neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 82 Kuwait country dynamics
  • Fig. 83 Kuwait neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 84 Company categorization
  • Fig. 85 Company market position analysis
  • Fig. 86 Strategic framework